MET and central nervous system cancer: In the PDGFRA#4 case, MET overexpression was most likely caused by the presence of a PTPRZ1-MET fusion, as PTPRZ1 is among the highest expressed genes in glioma, and the fusion places MET under the control of the PTPRZ1 promoter (Table S1).